We are an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
+0.65 ( 2.231% )
Pricing delayed by 20 minutes
Last updated 02/24/2021 04:00 PM
What product are you looking for?